Do Investors Have A Better Shot With BioNTech Or Moderna?

Ashley Hayes

Published on: 02/08/2021

While there may be little difference between the COVID-19 vaccines developed by BioNTech and Moderna, there are some significant differences between the two

BioNTechBiotech StocksCOVID VaccineCOVID-19InvestingInvestorsModernaStock MarketBiotech StocksCoronavirusCOVID-19 PandemicInvestInvestingInvestment StrategiesInvestors

Positioning For The Post-Pandemic Dividend Rebound

Ashley Hayes

Published on: 08/07/2021

As the U.S. turns the corner on COVID-19, substantial dividend growth is expected. Here’s where the biggest dividend increases are likely to occur – and one

COVID-19Dividend GrowthDividend IncreasesDividend ReboundDividendsInvestorsPost-Pandemic2021 Stock PicksCoronavirusCoronavirus PandemicCOVID-19 PandemicDividend StocksDividendsInvestInvestingInvestorsStock MarketStock Picks

The Best Biotech To Buy And Hold

Ashley Hayes

Published on: 17/05/2021

When it comes to the best long-term hold in biotech, this company could be the one – and its efforts related to infectious diseases, including COVID-19, is

Best Biotech InvestmentsBiotech SectorCOVID-19Long-Term HoldModernaModerna InvestmentsStock Market2021 Stock PicksBuy-and-Hold InvestingCoronavirusCoronavirus PandemicCOVID-19 PandemicHealth StocksInvestors

6 Over 6%: Attractive Income Streams Available At Attractive Prices

Ashley Hayes

Published on: 16/11/2020

Hit hard by the COVID-19 pandemic, there’s an opportunity right now for investors to pick up attractive income streams in the energy and real-estate sectors at

Attractive Stock PricesCOVID-19Energy SectorIncome StreamsInvestingReal Estate SectorREITsStock PriceStocksYields2020 Stock PicksAlternative InvestmentsCOVID-19 PandemicEnergy InvestmentsInvestInvestingInvestorsReal Estate InvestmentsStock MarketStocks to Watch